Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM)

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2016 by Woman's
Novo Nordisk A/S
Information provided by (Responsible Party):
Karen Elkind-Hirsch, Woman's Identifier:
First received: November 3, 2010
Last updated: June 16, 2016
Last verified: June 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2019
  Estimated Primary Completion Date: June 2018 (Final data collection date for primary outcome measure)